New migraine drug shows promise in clinical trial to treat patients with no other options
Ubrogepant, a new class of drug to treat acute migraine attacks, shows promise to treat patients who have previously lacked other options.
Healthcare
Ubrogepant, a new class of drug to treat acute migraine attacks, shows promise to treat patients who have previously lacked other options.